CIK 0001946563 · <br>Emerging growth company
60 DEGREES PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- SXTP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452406880
- Phone
- 202-327-5422
- Business address
- 1025 CONNECTICUT AVENUE NW, SUITE 1000, WASHINGTON, DC, 20036
Securities
- SXTP Common Stock Nasdaq
- SXTPW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-12 | MILLER TYRONE CFO | Grant or award | +60,000 | $0.27 | $16K | 161,928 |
| 2024-04-12 | MILLER TYRONE CFO | Option exercise · Restricted Stock Units | −60,000 | 15,000 | ||
| 2024-04-12 | DOW GEOFFREY S President and CEO | Option exercise | +68,000 | $0.27 | $18K | 745,625 |
| 2024-04-12 | DOW GEOFFREY S President and CEO | Option exercise · Restricted Stock Units | −68,000 | 17,000 | ||
| 2024-02-01 | XU CHERYL Director | Option exercise | +2,000 | 6,000 | ||
| 2024-01-31 | DOW GEOFFREY S President and CEO | Purchase | +25,974 | $0.38 | $10K | 703,599 |
| 2024-01-31 | DOW GEOFFREY S President and CEO | Purchase · Warrant | +25,974 | $0.01 | $260 | 25,974 |
| 2024-01-31 | XU CHERYL Director | Purchase | +200,000 | $0.38 | $75K | 424,934 |
| 2024-01-31 | XU CHERYL Director | Purchase · Warrant | +200,000 | $0.01 | $2K | 200,000 |
| 2023-12-31 | TOOVEY STEPHEN Director | Grant or award · Restricted Stock Units | +4,000 | 4,000 | ||
| 2023-12-31 | FIELD PAUL Director | Grant or award · Restricted Stock Units | +4,000 | 4,000 | ||
| 2023-12-31 | Allen Charles W Director | Grant or award · Restricted Stock Units | +4,000 | 4,000 | ||
| 2023-11-21 | MILLER TYRONE CFO | Grant or award · Restricted Stock Units | +75,000 | 75,000 | ||
| 2023-11-21 | DOW GEOFFREY S President and CEO | Grant or award · Restricted Stock Units | +85,000 | 85,000 | ||
| 2023-07-28 | Knight Therapeutics Inc Former 10% Owner | Conversion | +45,560 | $4.75 | $216K | 1,153,897 |
| 2023-07-28 | Knight Therapeutics Inc Former 10% Owner | Conversion | −2,162 | 78,803 | ||
| 2023-07-12 | MILLER TYRONE Chief Financial Officer | Grant or award · Non-Qualified Stock Options (right to buy) | +240,000 | 240,000 | ||
| 2023-07-12 | DOW GEOFFREY S President and CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +300,000 | 300,000 |
Page 3 of 3 · 58 trades